Clinical Development (China)

Pharmaron clinical services in China are an integrated component of our global clinical development service platform. Our team provides support for sponsors developing their clinical development strategies, either for the purpose of clinical development in China or internationally.

Pharmaron provides a full range of clinical trial services (phases I/II/III/IV) for regulatory submissions either locally or internationally. Our clinical development team in China works very closely with our Site Management Organization (SMO) and Patient Recruitment Organization (PRO) teams to ensure studies can be initiated as quickly as possible. The medical modalities include small molecules, large molecules and CGT products, as well as medical devices.

The clinical development service offerings include regulatory affairs, medical affairs, clinical operations, biometrics, pharmacovigilance, quantitative pharmacology and bioanalysis, supported by SMO and PRO, to meet the needs for clinical trials for innovative medical products and devices.